Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status
Clinical trial NCT04169178 · UNKNOWN
Trial details
- NCT number
- NCT04169178
- Sponsor
- Henlix, Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2022-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.